AL
Alta Life Sciences
Venture CapitalModerateAlta Life Sciences is a leading multistage venture capital investment firm in Spain.
8
Investments
2
Exits
$500M
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Alta Life Sciences.
Investment Thesis & Strategy
Alta Life Sciences invests in various stages of companies across various industries, with a focus on Spanish companies.
Investment Activity
Deals per year over the last 13 years
1
20100
20110
20120
20130
20140
20150
20162
20170
20180
20190
20202
20212
2022Portfolio Companies
Selected investments from their portfolio of 8 companies
S
Splice Bio
Biotech · Series A, 2022
G
Gate2Brain
Biotech · Seed, 2022
I
InnoUp Farma
Biotech · Series A, 2021
D
DeepUll
Biotech · Series A, 2021
B
Bionure
Biotech · Series A, 2017
M
Minoryx Therapeutics
Biotech · Series B, 2017
O
Oryzon Genomics
Biotech · Growth, 2010
Notable Exits
CompanyTypeYearValue / Acquirer
Minoryx TherapeuticsAcquisition2022—
Oryzon GenomicsIPO2015—
Frequently Asked Questions
Alta Life Sciences focuses on Series A, Series B, Series C+ stage investments.